breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - Антинеопластични средства - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - псориазис - Имуносупресори - treatment of moderate-to-severe plaque psoriasis in adults.
camzyos
bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - Други сърдечни препарати - treatment of symptomatic obstructive hypertrophic cardiomyopathy.
penicillin crystallisate tzf 1 000 000 iu powder for solution for injection
1 000 000 iu powder for solution for injection
penicillin crystallisate tzf 5 000 000 iu powder for solution for injection
5 000 000 iu powder for solution for injection
videx ec 250 mg gastro - resistant capsules, hard
bristol- myers squibb kft; - Диданозин - 250 mg gastro - resistant capsules, hard
videx ec 400 mg gastro - resistant capsules, hard
bristol- myers squibb kft; - Диданозин - 400 mg gastro - resistant capsules, hard
perfalgan 10 mg/ml solution for infusion
bristol- myers squibb kft; - Парацетамол - 10 mg/ml solution for infusion
maxipime l g powder for solution for injection
bristol- myers squibb kft; - Цефепим - l g powder for solution for injection
efferalgan 80 mg suppositories
bristol- myers squibb kft; - Парацетамол - 80 mg suppositories